Earnings Feed
Start Free
|4May 28, 7:25 PM ET

PHARMACYCLICS INC 4

4 · PHARMACYCLICS INC · Filed May 28, 2015

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
HALVORSON ERIC H
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−466→ 0 total
    Exercise: $65.56Exp: 2022-10-01→ Common Stock (466 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−522→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (522 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−344→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (344 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−195→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (195 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-26$261.25/sh−1,000$261,250→ 0 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−12,500→ 0 total
    Exercise: $14.26Exp: 2021-12-15→ Common Stock (12,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−340→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (340 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−187→ 0 total
    Exercise: $257.01Exp: 2025-04-07→ Common Stock (187 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−515→ 0 total
    Exercise: $59.28Exp: 2022-07-02→ Common Stock (515 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−252→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (252 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−306→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (306 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−267→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (267 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−440→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (440 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−327→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (327 underlying)
Footnotes (2)
  • [F1]Price reflects aggregate per share consideration paid pursuant to the Tender Offer.
  • [F2]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION